市場調查報告書

分子生物學用酵素、套件、試劑的全球市場 - 成長,趨勢,預測(2018年∼2023年)

Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 708599
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
分子生物學用酵素、套件、試劑的全球市場 - 成長,趨勢,預測(2018年∼2023年) Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球分子生物學用酵素、套件、試劑市場在2018年到2023年間,預測將以15.4%的年複合成長率擴大。

本報告提供分子生物學用酵素、套件、試劑的全球市場調查,市場概要,各類型、用途、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品與服務的威脅
    • 產業內的競爭

第6章 市場動態

  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品
    • 套件
    • 酵素
  • 各用途
    • 聚合酵素鏈鎖反應
    • 定序
    • 基因複製
    • 表觀遺傳學
    • 限制消化
    • 其他
  • 各終端用戶
    • 學術研究機關
    • 醫藥品、生物科技企業
    • 醫院、診斷中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 企業簡介

  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第9章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64141

Research & Development (R&D) is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind's benefit in the future. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors. As per the 2019 Global R&D funding forecast, the annual study published by R&D magazine, a publication of Advantage Business Marketing revealed that global R&D investment has increased by around 3.6% in 2019 to a total of USD 2.3 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus, increased research and R&D investments in the life science industry are augmenting the growth of the market.

In addition, technological advancements, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

Key Market Trends

Polymerase Chain Reaction Segment is Expected to Show Better Growth in the Forecast Years

Based on the Application, it is segmented into polymerase chain reaction (PCR), sequencing, epigenetics, and other applications. The growth of the segment is mainly attributed to the increasing prevalence of genetic, infectious, and chronic diseases. PCR based tests are increasingly being used to guide patient management, particularly in the fields of infectious disease, cancer, and congenital abnormalities. According to the WHO, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. The PCR techniques are routinely used for tumor profiling and detection of bacterial infections. Pertaining to broad applications of PCR in the field of molecular biology, the market segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Market

The molecular biology enzymes, kits and reagents market dominates the North America region due to increasing prevalence of genetic and chronic disorders, such as cancer, and favorable government initiatives. According to the American Cancer Society, approximately 1,735,350 new cancer cases were diagnosed in the United States in 2018 and there were around 609,640 deaths during the same year. Furthermore, growing geriatric population, along with rising R&D activities in the region is expected to drive the market over the forecast period.

Competitive Landscape

The global players into the molecular biology enzymes, kits, and reagents market are Agilent Technologies, Inc., F.Hoffmann-La Roche Ltd., Illumina, Inc., Lucigen Corporation, Merck KGaA, New England Biolabs, Promega Corporation, Qiagen NV, Takara Bio Inc. and Thermo Fisher Scientific.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
    • 4.2.2 Increasing R&D Activities in the Life Science Industry
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Limited Reimbursements for Genetic Testing
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Enzymes
    • 5.1.2 Kits and Reagents
  • 5.2 By Application
    • 5.2.1 Polymerase Chain Reaction
    • 5.2.2 Sequencing
    • 5.2.3 Epigenetics
    • 5.2.4 Other Applications
  • 5.3 By End Users
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Academic and Research Institutes
    • 5.3.3 Pharmaceutical and Biotechnology Companies
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 F. Hoffmann-La Roche Ltd
    • 6.1.3 Illumina Inc.
    • 6.1.4 Lucigen Corporation
    • 6.1.5 Merck KGaA
    • 6.1.6 New England Biolabs
    • 6.1.7 Promega Corporation
    • 6.1.8 Qiagen NV
    • 6.1.9 Takara Bio Inc.
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top